FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2171601681> ?p ?o ?g. }

• W2171601681 endingPage "354" @default.
• W2171601681 startingPage "345" @default.
• W2171601681 abstract "Chemotherapy with carboplatin and paclitaxel is the standard treatment for ovarian cancer patients. Although most patients initially respond to this treatment, few are cured. Resistance to chemotherapy is the major cause of treatment failure. We applied a quantitative proteomic approach based on ICAT/MS/MS technology to analyze tissues harvested at primary debulking surgery before the initiation of combination chemotherapy in order to identify potential naive or intrinsic chemotherapy response proteins in ovarian cancers. We identified 44 proteins that are overexpressed, and 34 proteins that are underexpressed in the chemosensitive tissue compared to the chemoresistant tissue. The overexpressed proteins identified in the chemoresistant tissue include 10 proteins (25.6%) belonging to the extracellular matrix (ECM), including decorin, versican, basigin (CD147), fibulin-1, extracellular matrix protein 1, biglycan, fibronectin 1, dermatopontin, alpha-cardiac actin (smooth muscle actin), and an EGF-containing fibulin-like extracellular matrix protein 1. Interesting proteins identified as overexpressed in the chemosensitive tissue include gamma-catenin (junction plakoglobin) and delta-catenin, tumor suppressor p53-binding protein 1 (53BP1), insulin-like growth factor-binding protein 2 (IGFBP2), proliferating cell nuclear antigen (PCNA), annexin A11, and 53 kDa selenium binding protein 1. Integrative analysis with expression profiling data of eight chemoresistant tissues and 13 chemosensitive tissues revealed that 16 proteins showed consistent changes at both the protein and the RNA levels. These include P53 binding protein 1, catenin delta 1 and plakoglobin, EGF-containing fibulin-like extracellular matrix protein 1 and voltage-dependent anion-selective channel protein 1. Our results suggest that chemotherapy response may be determined by multiple and complex system properties involving extracellular–matrix, cell adhesion and junction proteins." @default.
• W2171601681 created "2016-06-24" @default.
• W2171601681 creator A5006210822 @default.
• W2171601681 creator A5014137502 @default.
• W2171601681 creator A5028288310 @default.
• W2171601681 creator A5048050210 @default.
• W2171601681 creator A5052078795 @default.
• W2171601681 creator A5055046842 @default.
• W2171601681 creator A5066435196 @default.
• W2171601681 creator A5071158591 @default.
• W2171601681 creator A5079364585 @default.
• W2171601681 creator A5085306431 @default.
• W2171601681 date "2009-08-01" @default.
• W2171601681 modified "2023-10-16" @default.
• W2171601681 title "Quantitative Proteomics Analysis Integrated with Microarray Data Reveals That Extracellular Matrix Proteins, Catenins, and P53 Binding Protein 1 Are Important for Chemotherapy Response in Ovarian Cancers" @default.
• W2171601681 cites W17855875 @default.
• W2171601681 cites W1974195387 @default.
• W2171601681 cites W1975355340 @default.
• W2171601681 cites W1977504093 @default.
• W2171601681 cites W1977803522 @default.
• W2171601681 cites W1984341629 @default.
• W2171601681 cites W1986063172 @default.
• W2171601681 cites W1991291952 @default.
• W2171601681 cites W1995143851 @default.
• W2171601681 cites W1996474536 @default.
• W2171601681 cites W1999621653 @default.
• W2171601681 cites W2009976397 @default.
• W2171601681 cites W2010485879 @default.
• W2171601681 cites W2014044948 @default.
• W2171601681 cites W2015556811 @default.
• W2171601681 cites W2023096047 @default.
• W2171601681 cites W2023129794 @default.
• W2171601681 cites W2025422229 @default.
• W2171601681 cites W2026465178 @default.
• W2171601681 cites W2029220511 @default.
• W2171601681 cites W2042476998 @default.
• W2171601681 cites W2043610941 @default.
• W2171601681 cites W2055397209 @default.
• W2171601681 cites W2055580327 @default.
• W2171601681 cites W2058421409 @default.
• W2171601681 cites W2065190847 @default.
• W2171601681 cites W2084480265 @default.
• W2171601681 cites W2086216615 @default.
• W2171601681 cites W2104786760 @default.
• W2171601681 cites W2111208057 @default.
• W2171601681 cites W2112078820 @default.
• W2171601681 cites W2115954319 @default.
• W2171601681 cites W2131547351 @default.
• W2171601681 cites W2140009101 @default.
• W2171601681 cites W2147589023 @default.
• W2171601681 cites W2163669192 @default.
• W2171601681 cites W2164778107 @default.
• W2171601681 cites W2166933821 @default.
• W2171601681 cites W2328421677 @default.
• W2171601681 doi "https://doi.org/10.1089/omi.2009.0008" @default.
• W2171601681 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6469530" @default.
• W2171601681 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19422301" @default.
• W2171601681 hasPublicationYear "2009" @default.
• W2171601681 type Work @default.
• W2171601681 sameAs 2171601681 @default.
• W2171601681 citedByCount "75" @default.
• W2171601681 countsByYear W21716016812012 @default.
• W2171601681 countsByYear W21716016812013 @default.
• W2171601681 countsByYear W21716016812014 @default.
• W2171601681 countsByYear W21716016812015 @default.
• W2171601681 countsByYear W21716016812016 @default.
• W2171601681 countsByYear W21716016812017 @default.
• W2171601681 countsByYear W21716016812018 @default.
• W2171601681 countsByYear W21716016812019 @default.
• W2171601681 countsByYear W21716016812020 @default.
• W2171601681 countsByYear W21716016812021 @default.
• W2171601681 countsByYear W21716016812022 @default.
• W2171601681 countsByYear W21716016812023 @default.
• W2171601681 crossrefType "journal-article" @default.
• W2171601681 hasAuthorship W2171601681A5006210822 @default.
• W2171601681 hasAuthorship W2171601681A5014137502 @default.
• W2171601681 hasAuthorship W2171601681A5028288310 @default.
• W2171601681 hasAuthorship W2171601681A5048050210 @default.
• W2171601681 hasAuthorship W2171601681A5052078795 @default.
• W2171601681 hasAuthorship W2171601681A5055046842 @default.
• W2171601681 hasAuthorship W2171601681A5066435196 @default.
• W2171601681 hasAuthorship W2171601681A5071158591 @default.
• W2171601681 hasAuthorship W2171601681A5079364585 @default.
• W2171601681 hasAuthorship W2171601681A5085306431 @default.
• W2171601681 hasBestOaLocation W21716016812 @default.
• W2171601681 hasConcept C153911025 @default.
• W2171601681 hasConcept C189165786 @default.
• W2171601681 hasConcept C502942594 @default.
• W2171601681 hasConcept C86492073 @default.
• W2171601681 hasConcept C86803240 @default.
• W2171601681 hasConcept C95444343 @default.
• W2171601681 hasConceptScore W2171601681C153911025 @default.
• W2171601681 hasConceptScore W2171601681C189165786 @default.
• W2171601681 hasConceptScore W2171601681C502942594 @default.
• W2171601681 hasConceptScore W2171601681C86492073 @default.
• W2171601681 hasConceptScore W2171601681C86803240 @default.
• W2171601681 hasConceptScore W2171601681C95444343 @default.
• W2171601681 hasIssue "4" @default.

• next